https://pharmadog.xyz/news/368972 pharmadog en 2026-09-05T16:51:00.000Z Novartis and Ionis's pelacarsen fails to cut heart events despite lowering Lp(a) levels https://pharmadog.xyz/news/367075 pharmadog en 2026-09-05T10:00:45.000Z Novartis pauses CAR-T trials after three patient deaths https://pharmadog.xyz/news/366903 pharmadog en 2026-09-05T08:30:00.000Z STAT readers weigh in on MD vs DO training, AI accountability and surrogacy in medicine https://pharmadog.xyz/news/366691 pharmadog en 2026-09-05T07:42:51.000Z ADARx Pharmaceuticals, backed by AbbVie, files for IPO with three RNAi drugs in clinical trials https://pharmadog.xyz/news/364943 pharmadog en 2026-09-04T21:07:27.000Z Novartis' experimental heart drug pelacarsen fails pivotal Phase 3 trial https://pharmadog.xyz/news/365730 pharmadog en 2026-09-04T20:47:00.000Z Novartis' Lp(a) drug pelacarsen fails to cut heart attack or stroke risk in phase 3 trial https://pharmadog.xyz/news/365031 pharmadog en 2026-09-04T20:18:49.000Z FDA issues guidance to prevent newborn nutrition supply gap https://pharmadog.xyz/news/365032 pharmadog en 2026-09-04T19:38:04.000Z FDA grants accelerated approval for Etcamah combo therapy for advanced HR-positive, HER2-negative breast cancer https://pharmadog.xyz/news/364027 pharmadog en 2026-09-04T16:05:04.000Z Mass General Brigham drops Dana-Farber from its Medicare Advantage network starting Oct 1 https://pharmadog.xyz/news/364067 pharmadog en 2026-09-04T16:00:00.000Z AbbVie’s dual-acting myeloma drug etentamig meets main Phase 3 goal, showing longer progression-free survival https://pharmadog.xyz/news/364068 pharmadog en 2026-09-04T15:56:31.000Z Licensing deals with Chinese biotech stay strong as big pharma pours $550M+ into cancer and obesity pipelines https://pharmadog.xyz/news/364028 pharmadog en 2026-09-04T15:34:42.000Z Experts say Angelman syndrome drug failure leaves hope for similar antisense therapies https://pharmadog.xyz/news/363963 pharmadog en 2026-09-04T15:34:26.000Z Funding shortfall threatens progress of new Ebola vaccine candidates https://pharmadog.xyz/news/363747 pharmadog en 2026-09-04T14:47:16.000Z NeuShen Therapeutics raises over $80 million to advance three brain-health drug candidates https://pharmadog.xyz/news/363748 pharmadog en 2026-09-04T14:46:03.000Z Ionis secures FDA approval for zilganersen, its first solo neurology therapy for Alexander disease https://pharmadog.xyz/news/364077 pharmadog en 2026-09-04T14:19:00.000Z Foods Alive recalls organic moringa leaf powder over possible Salmonella contamination https://pharmadog.xyz/news/134233 pharmadog en 2026-09-04T14:06:00.000Z CLINUVEL to cut up to 20% of staff and move headquarters to New York https://pharmadog.xyz/news/363623 pharmadog en 2026-09-04T13:49:20.000Z MassBio and SCbio select 10 life science startups for Drive accelerator https://pharmadog.xyz/news/363643 pharmadog en 2026-09-04T13:46:42.000Z FDA revisits botanical drug pathway amid ongoing challenges for clozapine and pig kidney research https://pharmadog.xyz/news/363624 pharmadog en 2026-09-04T13:33:12.000Z Truist sees biotech rebound as M&A hits $136B and XBI climbs 34% in H1 https://pharmadog.xyz/news/363515 pharmadog en 2026-09-04T13:08:15.000Z Disabled workers face higher risk of losing health insurance, report highlights systemic gaps https://pharmadog.xyz/news/363516 pharmadog en 2026-09-04T13:02:26.000Z Bristol Myers Squibb pauses autoimmune CAR‑T trials after life‑threatening side effects https://pharmadog.xyz/news/364069 pharmadog en 2026-09-04T13:00:00.000Z Ionis receives FDA approval for Zanvastro, the first treatment for Alexander disease, as Pfizer partners on new ADC program https://pharmadog.xyz/news/363495 pharmadog en 2026-09-04T12:55:43.000Z Pfizer transfers Seagen ADC PF-08046031 to Medicus, adds $12M upfront payment amid acquisition doubts https://pharmadog.xyz/news/363303 pharmadog en 2026-09-04T12:00:51.000Z Thiel-backed Lindus Therapeutics sells CRO division and shifts focus to acquiring drug assets https://pharmadog.xyz/news/363210 pharmadog en 2026-09-04T11:31:09.000Z AbbVie’s etentamig shows strong survival and response gains in Phase 3 multiple myeloma trial https://pharmadog.xyz/news/363938 pharmadog en 2026-09-04T10:57:00.000Z Ionis secures FDA approval for zilganersen, a first treatment for Alexander disease https://pharmadog.xyz/news/363087 pharmadog en 2026-09-04T10:44:21.000Z Menarini secures European rights to Chinese GLP-1 obesity drug https://pharmadog.xyz/news/363771 pharmadog en 2026-09-04T10:35:00.000Z Menarini to launch Gan & Lee’s GLP-1 drug bofanglutide across Europe in $771 M partnership https://pharmadog.xyz/news/362857 pharmadog en 2026-09-04T08:30:00.000Z FDA lifts clozapine monitoring requirements, easing use for children with schizophrenia https://pharmadog.xyz/news/362855 pharmadog en 2026-09-04T08:30:00.000Z CDC-Pennsylvania dispute over measles death counts fuels drama amid rising cases https://pharmadog.xyz/news/362856 pharmadog en 2026-09-04T08:30:00.000Z Lindsay Clancy case highlights risks of fragmented US health care system https://pharmadog.xyz/news/365613 pharmadog en 2026-09-04T00:00:00.000Z Industry urges FDA to broaden prior-knowledge guidance for gene and cell therapies https://pharmadog.xyz/news/361151 pharmadog en 2026-09-03T22:30:00.000Z Gene-edited pig kidneys enable patients to go months without dialysis before receiving human transplants https://pharmadog.xyz/news/361131 pharmadog en 2026-09-03T22:21:29.000Z FDA approves Ionis’ Zanvastro as first disease-modifying therapy for Alexander disease https://pharmadog.xyz/news/361437 pharmadog en 2026-09-03T21:30:00.000Z American Regent, Inc. Issues Voluntary Nationwide Recall of Three Lots of Epinephrine Injection, USP 30 mg/ 30 mL (1 mg/mL) Due to the Presence of Particulate Matter and Lack of Assurance of Sterility